US IPO Banker Fees Power Through Shutdown to Top Last Year

(Bloomberg) — Fees from underwriting US IPOs, stock sales and convertible bonds have already surpassed last year’s, even as tariff angst and the government shutdown curbed dealmaking opportunities.

With a few weeks left in 2025, fees from stock and convertible bond sales by US-listed companies total $8.78 billion for the year through Dec. 2, versus $8.06 billion in all of 2024, according to London Stock Exchange Group Plc data.

A record year for convertible bond issues, as well as an IPO market helped by a surge in blank-check firm listings, underpinned the rebound in fees.

The tariff back-and-forth and the federal government shutdown that halted some of the US Securities and Exchange Commission’s functions probably meant about a quarter of this year was lost to dealmakers, said Mangesh Ghogre, founder of New York-based One Capita Advisors and a former head of equity capital markets at Nomura Holdings Inc.’s India unit.

“With fewer windows, the car, so to speak, was running on three tires this year,” Ghogre said.

The trifecta of relatively high interest rates, soaring equity prices and elevated single-stock volatility made convertible bonds especially attractive this year to companies seeking the lowest-cost capital, making it the fastest-growing product within ECM with $2.38 billion in fees, up 46% from 2024. There were nine single or dual-tranche offerings raising more than $2 billion, led by two-part deals from artificial intelligence data center operator Nebius Group NV and crypto exchange Coinbase Global Inc. 

Helped by a decent stretch from June to September when markets were wide open for business, as well as a substantial pickup in SPAC listings, banks have still generated $2.45 billion of fees this year from US-traded IPOs. That’s a nearly 13% increase from last year, according to the LSEG data, led by the listings for gas exporter Venture Global Inc., payments firm Klarna Group Plc and AI infrastructure company CoreWeave Inc.

As in most years, the biggest source of fees for the banks’ ECM units was sales of shares in already listed companies. These generated $3.94 billion of fees, 7% behind last year’s haul, as the dealmaking hiatuses made it harder to confidently time offerings.

February’s $13.1 billion sell-down by Toronto-Dominion Bank of its stake in Charles Schwab Corp. holds the mantle of this year’s biggest stock sale, well ahead of insurance broker Brown & Brown Inc.’s $4.4 billion offering in June.

The biggest sectors in terms of ECM fees across all products this year were financials – a category which includes vehicles such as SPAC IPOs — and technology. Health care, last year’s busiest sector, was weighed down by policy uncertainty in Washington.

While this year’s fees are modestly higher than 2024’s, they remain well below the $20.4 billion reeled in during the easy money conditions of 2021 and the 10-year average of $9.41 billion, LSEG’s data show.

With the government shutdown delaying some activity, bankers are optimistic that next year will be bigger again in terms of fees and share-sale volume.

“The highway could turn into a runway in 2026 given expected interest rate cuts and assuming the full year will be available,” Ghogre said.

More stories like this are available on bloomberg.com

  • Aniket Pujari

    Aniket Pujari

    Aniket Pujari, a graduate in Financial Markets, is the founder of Minute To Know News, a digital platform providing daily news updates on cryptocurrencies, finance, and economics. With a passion for finance and technology, Aniket has been exploring the world of cryptocurrencies since 2015, building a deep understanding of these rapidly evolving industries.

    Related Posts

    Park Medi IPO allotment to be finalised today. Here’s GMP, step-by-step guide on how to check status online

    Park Medi IPO allotment: After witnessing a strong response from investors during the three-day subscription period, the focus has now shifted to Park Medi IPO allotment. The allotment of the…

    Nephrocare Health IPO allotment likely today: GMP, step-by-step guide to check allotment status online

    Nephrocare Health Services IPO Allotment: The initial public offering (IPO) of Nephrocare Health Services saw robust investor participation, and attention has now turned to the IPO allotment date, which is…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Park Medi IPO allotment to be finalised today. Here’s GMP, step-by-step guide on how to check status online

    Solar companies making big profits now, but earnings may slow in next 3 years: DAM Capital

    Nephrocare Health IPO allotment likely today: GMP, step-by-step guide to check allotment status online

    Buy or sell: Vaishali Parekh recommends three intraday stocks to buy today — 15 December 2025

    Japans Nikkei sinks as tech shares track US peers lower

    Stocks to watch: Paytm, Wipro, Tata Steel, BEL, Dr Reddy’s among 10 shares in focus today; Check list here